![]() ARTPred ARTPred is a research driven biotech company in the field of IVF. ARTPred is dedicated to develop a predictive test (PREDICTIFE) for embryo implantation, ased on urinary and vaginal microbiome profiling. | ![]() Kymab Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics. | ![]() Alcresta Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases. | ![]() Gobiquity Gobiquity, Inc. (formerly ICHECK Health Connection, Inc.) provides mobile applications for the early detection and tracking of eye diseases in the United States | ||
Founding Date | Founding Date 2017 | Founding Date 2014 | Founding Date 2009 | Founding Date 2011 | Founding Date 2011 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Mountain View, US HQ | Locations 's-Hertogenbosch, NL HQ | Locations Cambridge, GB HQ | Locations Newton, US HQ | Locations Portland, US HQ |
Employees | Employees 62 | Employees 5 | Employees 407% decrease | Employees 82 | Employees 455% increase |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 100m (over 9 years ago) | Latest funding round $ 60m (over 8 years ago) | Latest funding round $ 6m (almost 10 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 220.4m | Total funding raised $ 139.4m | Total funding raised $ 6.8m |

ARTPred is a research driven biotech company in the field of IVF. ARTPred is dedicated to develop a predictive test (PREDICTIFE) for embryo implantation, ased on urinary and vaginal microbiome profiling.
View company
Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics.
View company
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.
View company
Gobiquity, Inc. (formerly ICHECK Health Connection, Inc.) provides mobile applications for the early detection and tracking of eye diseases in the United States
View company